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Abstract 
A 61-year-old Japanese male was seen at an outside hospital with abdominal pain and 
distention. An intraabdominal mass was found on abdominal computed tomography (CT), 
and he was referred for further evaluation. He was afebrile, with mild tenderness in the 
upper abdomen and massive distention. Routine blood work showed severe inflammation 
and anemia. Repeat CT showed a large solitary heterogeneous mass, 25 cm in diameter, in 
the left upper quadrant with evidence of intratumoral bleeding and irregular enhancement 
peripherally. There was no clear distinction between the mass and the peripheral organs. 
Surgery was performed with persistent anemia and exacerbation of abdominal pain. Lateral 
segmentectomy, total gastrectomy, cholecystectomy and partial resection of the diaphragm 
and parietal peritoneum were performed. The final diagnosis was cholangiocarcinoma with 
sarcomatous changes. On the 16th postoperative day a CT scan revealed recurrent tumor. 
The patient died on the 34th postoperative day from rapid tumor progression. 
 
Introduction 
Epithelial tumors with sarcomatous features are occasionally observed in various 
organs, including the liver [1]. Most sarcomatous carcinomas in the liver are regarded 
as sarcomatous differentiation from hepatocellular carcinoma, and their clinical 
characteristics and pathologic significance have been satisfactorily elucidated [2]. 
Intrahepatic cholangiocarcinoma with sarcomatous changes is very rare. Sarcomatous 
transformation has been reported in about 3.9–9.4% of hepatocellular carcinomas at 
autopsy and in about 4.5% of cholangiocarcinomas [3]. Clinical as well as imaging and 
pathologic information regarding this tumor are still limited. Preoperatively, it may be 
difficult to establish the definitive diagnosis. Resection is important for prolongation of 
survival. The optimal treatment of these rare lesions is unclear, partly because of the 
typically aggressive clinical course. The present case demonstrates some typical 
features associated with these rare tumors.  
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Case Report 
A 61-year-old Japanese male was seen at an outside hospital with abdominal pain and distention. 
An intraabdominal mass was found on abdominal computed tomography (CT), and he was referred 
for further evaluation. Both parents had died of hepatic cirrhosis. On physical examination, he was 
afebrile, with mild tenderness in the upper abdomen and with massive distention. Routine blood tests 
showed: WBC 24,300/μl, Hb 7.3 g/dl, FDP 123.7 μg/ml, D-dimer 111.2 ng/ml, T-Bili 1.24 mg/dl, AST 
35 mU/ml, LDH 810 mU/ml, ALP 392 mU/ml, ChE 99 mU/ml, CRP 18.28 mg/dl, HBs antigen negative, 
HCV antibody positive, CEA 1.2 ng/ml, and CA19-9 5 U/ml. Repeat CT showed a large solitary 
heterogeneous mass, 25 cm in diameter, in the left upper quadrant with evidence of intratumoral 
bleeding and irregular enhancement peripherally (arrowhead, fig. 1). There was no clear distinction 
between the mass and the left lateral segment of the liver. The anterior wall of the stomach was 
diffusely adherent to the posterior side of the mass. The left side of the diaphragm was also invaded 
(arrowhead, fig. 2). The tumor seemed to originate from the gastric wall and was suspected to be a 
gastrointestinal stromal tumor. Needle biopsy revealed only a few spindle-shaped atypical cells. 
Surgery was performed due to persistent anemia and exacerbation of abdominal pain. 
Intraoperative findings revealed that the tumor was densely adherent to the lateral segment of the 
liver, gallbladder, anterior wall of the stomach, left side of the diaphragm and parietal peritoneum. 
Lateral segmentectomy, total gastrectomy, cholecystectomy and partial resection of the diaphragm 
and parietal peritoneum were performed, with a Roux-en-Y reconstruction. The tumor measured 
20 × 15 × 8 cm. Hematoxylin and eosin staining of histologic sections of the resected specimen 
showed a malignant neoplasm with undifferentiated spindle cells. Malignant cells with glandular 
formations similar to intrahepatic bile ducts showed a transition from a differentiated component 
to an undifferentiated one between the tumor and the liver. Tumor cells invaded the intrahepatic 
bile duct and replaced normal bile duct epithelium. The carcinomatous component (<10% of the 
cells) stained positive for cytokeratin-7 and cytokeratin-19, but negative for hepatocytes. The 
sarcomatous component (~90% of the cells) stained positive for vimentin and keratin-1, but negative 
for cytokeratin-7, cytokeratin-19 and hepatocytes. The adenocarcinoma appeared to be derived from 
the intrahepatic bile duct with transformation to sarcomatous cells. The final diagnosis was 
cholangiocarcinoma with sarcomatous changes. On the 16th postoperative day, a CT scan revealed 
recurrent tumor. The patient was discharged from the hospital for supportive care and died on the 
34th postoperative day from rapid tumor progression. 
Discussion 
Sarcomatous transformation has been reported to occur in a hepatocellular 
carcinoma previously treated with transcatheter arterial chemoembolization [3]. 
There have been no reports concerning the relationship between sarcomatous 
cholangiocarcinoma and anticancer therapy. Nakajima et al. reported 7 cases of 
cholangiocarcinoma with sarcomatous changes with a median age of 69 years and 
abdominal pain as the main presenting symptom [4]. There were no disease-specific 
findings based on serum chemistry. Abdominal CT showed low-density lesions 
enhanced at the periphery resembling ordinary cholangiocarcinoma, which were 
difficult to differentiate by imaging alone. In the present case, a solid lesion and a 
cystic lesion were found on CT, suggesting a fragile tumor such as a gastrointestinal 
stromal tumor. Immunohistochemical studies are necessary to establish the diagnosis. 
Most previously reported cases showed cytokeratin and vimentin expression in the 
sarcomatous component characteristic of epithelial derivation, as seen in the present 
case [3–5]. Gupta et al. reported cytomorphological features of cholangiocarcinoma 
with sarcomatous changes, with spindle-shaped cells, scanty cytoplasm and 
hyperchromatic nuclei [6]. Although these are useful for preoperative diagnosis, needle 
biopsy may be contraindicated with the risk of intratumor hemorrhage and peritoneal 
dissemination, as in our case.  
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It has been reported that the prognosis for cholangiocarcinoma with sarcomatous 
changes is worse than that for typical cholangiocarcinoma [3]. The factors that account 
for the poor prognosis may be ascribed to the intrahepatic development, especially the 
high potential of the sarcomatous component to metastasize [3]. Kaibori et al. reported 
that the survival rate of patients with surgically resected disease was significantly 
higher than that in patients without resection [5]. There is however no information 
available about the optimal adjuvant treatment after resection. Malhotra et al. reported 
combination chemotherapy with gemcitabine and cisplatin as a potential treatment for 
controlling disease progression [3]. In our case, there was no time to give adjuvant 
therapy because of rapid recurrence and general deterioration. 
Cholangiocarcinoma with sarcomatous changes is an extremely rare tumor 
composed of mixed malignant epithelial and mesenchymal cells. The outcome of this 
case shows that this neoplasm generally pursues a highly aggressive and malignant 
clinical course, with rapid growth and wide local infiltration, leading to poor prognosis. 
Radical surgery with adjuvant chemotherapy and close follow-up may be important in 
the effective management of this disease. 
 
 
 
 
 
 
Fig. 1. CT scan of the abdomen showed a tumor with solid and cystic components. The arrowhead 
shows intratumoral bleeding. 
 
  
Case Rep Gastroenterol 2012;6:1–4 
DOI: 10.1159/000335883 
Published online: 
January 4, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
 
4 
 
Fig. 2. CT demonstrated no sharp delineation between the tumor and the lateral lobe of the liver 
(arrowhead). The tumor invaded the diaphragm. 
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